Intelligent Bio Solutions
INBS
13 hedge funds and large institutions have $2.52M invested in Intelligent Bio Solutions in 2024 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 4 closing their positions.
1,563% more capital invested
Capital invested by funds: $151K → $2.52M (+$2.36M)
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
125% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 4
63% more funds holding
Funds holding: 8 → 13 (+5)
2.06% more ownership
Funds ownership: 0.04% → 2.1% (+2.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
+$854K |
| 2 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$448K |
| 3 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$448K |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$448K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$64.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$50K |
| 2 |
OAC
OMERS Administration Corp
Toronto,
Ontario, Canada
|
-$14.3K |
| 3 |
Two Sigma Investments
New York
|
-$11.5K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$9.95K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.39K |
INBS Hedge Fund Activity: Q1 2024 in Review
13 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Intelligent Bio Solutions (INBS) for Q1 2024, worth a combined $2.52M — up 1,563% from $151K a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new INBS positions and 4 closed out — a net gain of 5 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Alyeska Investment Group, opening a new position worth an estimated $854K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $50K sold.
- 13 institutional investors held Intelligent Bio Solutions (INBS) as of Q1 2024, up from 8 in Q4 2023.
- Funds reported $2.52M of Intelligent Bio Solutions stock for Q1 2024, up 1,563% quarter-over-quarter.
- 9 funds opened new Intelligent Bio Solutions positions in Q1 2024 and 4 closed out, a net change of +5 holders.
- The largest Intelligent Bio Solutions buyer in Q1 2024 was Alyeska Investment Group, an estimated $854K added.
- The largest Intelligent Bio Solutions seller in Q1 2024 was Renaissance Technologies, an estimated $50K sold.
Based on aggregated 13F filings for Q1 2024.